Providing market intelligence for more than 35 years

In The News

Netflix, Inc. (NASDAQ:NFLX) Users Sharing Account Passwords, Details With Others

In fact, according to a recent study from Parks Associates, Netflix could lose an estimated $500 million in 2015 because of global account credential-sharing. Moreover, “The Cost of Piracy” report discovered that six percent of U.S. households utilize a streaming service unregistered by any household member. What’s troubling is that it’s mostly young people taking part in this practice.

Netflix, which has about 65 million international users and has been growing thanks to overseas adoption, does offer multiple account types:

  • Basic: $8 per month; number of screens to watch on is just one.
  • Standard: $9 per month; number of screens to watch on is two.
  • Premium: $12 per month; number of screens to watch on is four.

From the article "Netflix, Inc. (NASDAQ:NFLX) Users Sharing Account Passwords, Details With Others" by Andrew Moran.

Previously In The News

Parks: US Churn Rate For OTT Services Is 19%

This is according to Parks Associates’ latest ‘OTT Video Market Tracker’ stats, which said that overall churn rate for OTT services has been roughly stable for the past year. At the end of 2015, 20...

Cord Cutters Face A Sea Of Streaming Options

Hartstein’s decision was made easier because of a flood of Internet streaming services that allows consumers to cobble together their own video packages. There are more than 100 Internet video service...

Over Two-Thirds Of U.S. Smartphone Owners Stream Music Daily

A recent Parks Associates report reveals that 68 percent of U.S. smartphone owners listen to streaming music every day, for an average of 45 minutes per day. Amazon Prime Music emerged as the most pop...

Morning Read: Pharma Changes Afoot As Valeant Courts A New CEO And Novartis U.S. Head Exits

Less than half of caregivers with a smartphone use apps aimed at caregivers, according to a report by Parks Associates. — MobiHealthNews From the article "Morning Read: Pharma Changes Afoot As Vale...